Silibinin activated ROS-p38-NF-κB positive feedback and induced autophagic death in human fibrosarcoma HT1080 cells.
Our previous results demonstrated that silibinin induced autophagic and apoptotic cell death dependent on reactive oxygen species (ROS especially H(2)O(2) and [image omitted] ) in HT1080 cells. In this study, we further show that p38-NF-κB pathway is involved in silibinin-induced ROS-mediated autophagy. Cells were pretreated with serum-free media for 24 h before being treated with silibinin. Generation of ROS and autophagy was detected in 15 min and 1 h, respectively. Development of autophagy was supported by an upregulated expression of Beclin-1 and conversion of light chain (LC3-I-LC3-II). Expression of p38/p-p38 and transposition of NF-κB from cytoplasm to nuclei were also increased. Inhibitors of p38 and NF-κB and scavengers of H(2)O(2) and O(2)(*-) reduced both generation of ROS and simultaneous occurrence of silibinin-induced autophagy. Besides, expression of p38/p-p38 and transposition of NF-κB from cytoplasm to nuclei were decreased by these two ROS scavengers. ROS and p38-NF-κB pathway were possibly cooperated in a positive feedback mechanism. Inhibition of p38, NF-κB, H(2)O(2), or O(2)(*-) rescued cells from silibinin-induced death in a long-term (12 h) manner. According to the previous study that silibinin-induced autophagy was a positive regulator of apoptotic cell death, it was possible that ROS and p38-NF-κB mediated silibinin-induced autophagy and eventually led to cell death.
China-Japan Research Institute of Medical and Pharmaceutical Sciences, Shenyang Pharmaceutical University, Shenyang, China.
Wen-Jun
WJ
Duan
Qi-Sheng
QS
Li
Ming-Yu
MY
Xia
Shin-Ichi
S
Tashiro
Satoshi
S
Onodera
Takashi
T
Ikejima
D017209:Apoptosis / Q000187:drug effects; D001343:Autophagy / Q000187:drug effects*; D016923:Cell Death / Q000187:drug effects; D005354:Fibrosarcoma / Q000188:drug therapy*; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D016328:NF-kappa B / Q000187:drug effects*; D017382:Reactive Oxygen Species / Q000378:metabolism; D000077385:Silybin; D012838:Silymarin / Q000494:pharmacology*; D013481:Superoxides / Q000378:metabolism; D048051:p38 Mitogen-Activated Protein Kinases / Q000187:drug effects*
D016328:NF-kappa B; D017382:Reactive Oxygen Species; D012838:Silymarin; D013481:Superoxides; D000077385:Silybin; D006861:Hydrogen Peroxide; D048051:p38 Mitogen-Activated Protein Kinases